Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:AIMT
Tag: NASDAQ:AIMT
Aimmune Therapeutics Inc (NASDAQ:AIMT) had its Outperform rating reiterated by Wedbush...
ME Staff
-
July 2, 2019
0
AIMMUNE THERAPEUTICS, INC. (NASDAQ:AIMT) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
June 19, 2019
0
Aimmune Therapeutics Inc (NASDAQ:AIMT) had its Outperform rating reiterated by Wedbush...
ME Staff
-
March 19, 2019
0
AIMMUNE THERAPEUTICS, INC. (NASDAQ:AIMT) Files An 8-K Other Events
ME Staff 8-k
-
March 18, 2019
0
Aimmune Therapeutics Inc (NASDAQ:AIMT) had its Outperform rating reiterated by Wedbush...
ME Staff
-
February 5, 2019
0
AIMMUNE THERAPEUTICS, INC. (NASDAQ:AIMT) Files An 8-K Entry into a Material...
ME Staff 8-k
-
January 4, 2019
0
Aimmune Therapeutics Inc (NASDAQ:AIMT) price target set to $80.00 by Roth...
ME Staff
-
December 13, 2018
0
Aimmune Therapeutics Inc (NASDAQ:AIMT) price target set to $64.00 by Cantor...
ME Staff
-
December 13, 2018
0
Aimmune Therapeutics Inc (NASDAQ:AIMT) price target set to $62.00 by Cantor...
ME Staff
-
October 15, 2018
0
Aimmune Therapeutics Inc (NASDAQ:AIMT) price target set to $80.00 by Roth...
ME Staff
-
October 9, 2018
0
1
2
3
...
7
Page 1 of 7
